by Plus Therapeutics | May 17, 2024 | Uncategorized
Exciting News! Our partner, Head for the Cure Foundation has launched a new patient and caregiver resource, “Join Your Path to Hope!” JPH gives personalized guidance and resources for every step of your brain tumor journey within three different paths: medical,...
by Plus Therapeutics | May 10, 2024 | Uncategorized
Thank you to everyone who stopped by our booth at the AANS annual meeting to learn more about our ReSPECT Recurrent Glioblastoma and Leptomeningeal Metastases clinical trials! If you missed us and would like more information, you can send us an email at...
by Plus Therapeutics | May 3, 2024 | Uncategorized
Reminder to come stop by the Plus Therapeutics booth #1057 at the American Association of Neurological Surgeons (AANS) annual conference this weekend in Chicago! Our team will be in the exhibit hall during the entire conference, so come say hello 👋 Home #AANS2024...
by Plus Therapeutics | May 1, 2024 | Uncategorized
Brain tumor research is at the heart of what we do. Our team focuses every day on how to fight for a cure, and we are passionate about the Brain Cancer community. 🧠🎗️ We have some great education events and news this month that we look forward to sharing with you all,...
by Plus Therapeutics | Apr 26, 2024 | Uncategorized
Come join us at the American Association of Neurological Surgeons (AANS) Annual Meeting in Chicago, IL next week! Visit our booth to learn about our #clinicaltrials for #patients with recurrent #glioblastoma, leptomeningeal #metastases, & pediatric #braincancer...
by Plus Therapeutics | Apr 25, 2024 | Uncategorized
“Plus Therapeutics’ commitment to revolutionizing cancer treatment extends beyond this latest award. With $23 million in active awards support, the company is at the forefront of targeted radiotherapeutic research. Moreover, ongoing trials, including...
Recent Comments